{"count": 56, "results": [{"_id": "35356068", "pmid": 35356068, "pmcid": "PMC8934205", "title": "Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways", "journal": "Cardiovasc Ther", "authors": ["Wang X", "Yan K", "Wen C", "Wang J"], "date": "2022-03-12T00:00:00Z", "doi": "10.1155/2022/8430733", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "8430733", "score": 50279.746, "text_hl": "This suggests that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ combined with resistance training significantly improves the cardiac function of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@CHF@@@ (Figure 1).", "citations": {"NLM": "Wang X, Yan K, Wen C, Wang J. Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways Cardiovasc Ther. 2022;2022():8430733. PMID: 35356068", "BibTeX": "@article{35356068, title={Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways}, author={Wang X and Yan K and Wen C and Wang J}, journal={Cardiovasc Ther}, volume={2022}, pages={8430733}}"}}, {"_id": "36970211", "pmid": 36970211, "pmcid": "PMC10031343", "title": "Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms", "journal": "Acta Pharm Sin B", "authors": ["Yang Y", "Feng K", "Yuan L", "Liu Y", "Zhang M", "Guo K", "Yin Z", "Wang W", "Zhou S", "Sun H", "Yan K", "Yan X", "Wang X", "Duan Y", "Hu Y", "Han J"], "date": "2023-03-01T00:00:00Z", "doi": "10.1016/j.apsb.2022.11.012", "meta_date_publication": "2023 Mar", "meta_volume": "13", "meta_issue": "3", "meta_pages": "1036-1052", "score": 50273.906, "text_hl": "Therefore, we hypothesized that CDDP or CDDP combined @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ can reduce @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@. ", "citations": {"NLM": "Yang Y, Feng K, Yuan L, Liu Y, Zhang M, Guo K, Yin Z, Wang W, Zhou S, Sun H, Yan K, Yan X, Wang X, Duan Y, Hu Y, Han J. Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms Acta Pharm Sin B. 2023 Mar;13(3):1036-1052. PMID: 36970211", "BibTeX": "@article{36970211, title={Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms}, author={Yang Y and Feng K and Yuan L and Liu Y and Zhang M and Guo K and Yin Z and Wang W and Zhou S and Sun H and Yan K and Yan X and Wang X and Duan Y and Hu Y and Han J}, journal={Acta Pharm Sin B}, volume={13}, number={3}, pages={1036-1052}}"}}, {"_id": "40560599", "pmid": 40560599, "title": "Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis.", "journal": "JAMA", "authors": ["Zhao Z", "Huang Q"], "date": "2025-07-22T00:00:00Z", "doi": "10.1001/jama.2025.6141", "meta_date_publication": "2025 Jul 22", "meta_volume": "334", "meta_issue": "4", "meta_pages": "365", "score": 50269.117, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Rifaximin @CHEMICAL_MESH:D000078262 @@@Rifaximin@@@ for @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Decompensated Cirrhosis@@@.", "citations": {"NLM": "Zhao Z, Huang Q. Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis. JAMA. 2025 Jul 22;334(4):365. PMID: 40560599", "BibTeX": "@article{40560599, title={Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis.}, author={Zhao Z and Huang Q}, journal={JAMA}, volume={334}, number={4}, pages={365}}"}}, {"_id": "40560563", "pmid": 40560563, "title": "Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis.", "journal": "JAMA", "authors": ["Agarwal S", "Rana R", "Sharma S"], "date": "2025-06-25T00:00:00Z", "doi": "10.1001/jama.2025.6135", "meta_date_publication": "2025 Jun 25", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50268.906, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Rifaximin @CHEMICAL_MESH:D000078262 @@@Rifaximin@@@ for @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Decompensated Cirrhosis@@@.", "citations": {"NLM": "Agarwal S, Rana R, Sharma S. Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis. JAMA. 2025 Jun 25;():. PMID: 40560563", "BibTeX": "@article{40560563, title={Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis.}, author={Agarwal S and Rana R and Sharma S}, journal={JAMA}}"}}, {"_id": "40560558", "pmid": 40560558, "title": "Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis.", "journal": "JAMA", "authors": ["Pei YY"], "date": "2025-07-22T00:00:00Z", "doi": "10.1001/jama.2025.6132", "meta_date_publication": "2025 Jul 22", "meta_volume": "334", "meta_issue": "4", "meta_pages": "364-365", "score": 50268.88, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Rifaximin @CHEMICAL_MESH:D000078262 @@@Rifaximin@@@ for @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Decompensated Cirrhosis@@@.", "citations": {"NLM": "Pei YY. Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis. JAMA. 2025 Jul 22;334(4):364-365. PMID: 40560558", "BibTeX": "@article{40560558, title={Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis.}, author={Pei YY}, journal={JAMA}, volume={334}, number={4}, pages={364-365}}"}}, {"_id": "40560602", "pmid": 40560602, "title": "Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis.", "journal": "JAMA", "authors": ["Su C"], "date": "2025-07-22T00:00:00Z", "doi": "10.1001/jama.2025.6138", "meta_date_publication": "2025 Jul 22", "meta_volume": "334", "meta_issue": "4", "meta_pages": "365-366", "score": 50268.79, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Rifaximin @CHEMICAL_MESH:D000078262 @@@Rifaximin@@@ for @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Decompensated Cirrhosis@@@.", "citations": {"NLM": "Su C. Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis. JAMA. 2025 Jul 22;334(4):365-366. PMID: 40560602", "BibTeX": "@article{40560602, title={Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis.}, author={Su C}, journal={JAMA}, volume={334}, number={4}, pages={365-366}}"}}, {"_id": "40560565", "pmid": 40560565, "title": "Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis-Reply.", "journal": "JAMA", "authors": ["Pose E", "Ginès P"], "date": "2025-07-22T00:00:00Z", "doi": "10.1001/jama.2025.6144", "meta_date_publication": "2025 Jul 22", "meta_volume": "334", "meta_issue": "4", "meta_pages": "366", "score": 50266.7, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Rifaximin @CHEMICAL_MESH:D000078262 @@@Rifaximin@@@ for @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Decompensated Cirrhosis@@@-Reply.", "citations": {"NLM": "Pose E, Ginès P. Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis-Reply. JAMA. 2025 Jul 22;334(4):366. PMID: 40560565", "BibTeX": "@article{40560565, title={Simvastatin and Rifaximin for Patients With Decompensated Cirrhosis-Reply.}, author={Pose E and Ginès P}, journal={JAMA}, volume={334}, number={4}, pages={366}}"}}, {"_id": "39908052", "pmid": 39908052, "title": "Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.", "journal": "JAMA", "authors": ["Pose E", "Jiménez C", "Zaccherini G", "Campion D", "Piano S", "Uschner FE", "de Wit K", "Roux O", "Gananandan K", "Laleman W", "Solé C", "Alonso S", "Cuyàs B", "Ariza X", "Juanola A", "Ma AT", "Napoleone L", "Gratacós-Ginès J", "Tonon M", "Pompili E", "Sánchez-Delgado J", "Allegretti AS", "Morales-Ruiz M", "Carol M", "Pérez-Guasch M", "Fabrellas N", "Pich J", "Martell C", "Joyera M", "Domenech G", "Ríos J", "Torres F", "Serra-Burriel M", "Hernáez R", "Solà E", "Graupera I", "Watson H", "Soriano G", "Bañares R", "Mookerjee RP", "Francoz C", "Beuers U", "Trebicka J", "Angeli P", "Alessandria C", "Caraceni P", "Vargas VM", "Abraldes JG", "Kamath PS", "Ginès P", "LIVERHOPE Consortium"], "date": "2025-02-05T00:00:00Z", "doi": "10.1001/jama.2024.27441", "meta_date_publication": "2025 Feb 5", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50266.67, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Rifaximin @CHEMICAL_MESH:D000078262 @@@Rifaximin@@@ in @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Decompensated Cirrhosis@@@: A Randomized Clinical Trial.", "citations": {"NLM": "Pose E, Jiménez C, Zaccherini G, Campion D, Piano S, Uschner FE, de Wit K, Roux O, Gananandan K, Laleman W, Solé C, Alonso S, Cuyàs B, Ariza X, Juanola A, Ma AT, Napoleone L, Gratacós-Ginès J, Tonon M, Pompili E, Sánchez-Delgado J, Allegretti AS, Morales-Ruiz M, Carol M, Pérez-Guasch M, Fabrellas N, Pich J, Martell C, Joyera M, Domenech G, Ríos J, Torres F, Serra-Burriel M, Hernáez R, Solà E, Graupera I, Watson H, Soriano G, Bañares R, Mookerjee RP, Francoz C, Beuers U, Trebicka J, Angeli P, Alessandria C, Caraceni P, Vargas VM, Abraldes JG, Kamath PS, Ginès P, LIVERHOPE Consortium. Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial. JAMA. 2025 Feb 5;():. PMID: 39908052", "BibTeX": "@article{39908052, title={Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.}, author={Pose E and Jiménez C and Zaccherini G and Campion D and Piano S and Uschner FE and de Wit K and Roux O and Gananandan K and Laleman W and Solé C and Alonso S and Cuyàs B and Ariza X and Juanola A and Ma AT and Napoleone L and Gratacós-Ginès J and Tonon M and Pompili E and Sánchez-Delgado J and Allegretti AS and Morales-Ruiz M and Carol M and Pérez-Guasch M and Fabrellas N and Pich J and Martell C and Joyera M and Domenech G and Ríos J and Torres F and Serra-Burriel M and Hernáez R and Solà E and Graupera I and Watson H and Soriano G and Bañares R and Mookerjee RP and Francoz C and Beuers U and Trebicka J and Angeli P and Alessandria C and Caraceni P and Vargas VM and Abraldes JG and Kamath PS and Ginès P and LIVERHOPE Consortium}, journal={JAMA}}"}}, {"_id": "34964311", "pmid": 34964311, "pmcid": "PMC9035579", "title": "Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis", "journal": "Hepatol Commun", "authors": ["Pose E", "Solà E", "Lozano JJ", "Juanola A", "Sidorova J", "Zaccherini G", "de Wit K", "Uschner F", "Tonon M", "Kazankov K", "Jiménez C", "Campion D", "Napoleone L", "Ma AT", "Carol M", "Morales-Ruiz M", "Alessandria C", "Beuers U", "Caraceni P", "Francoz C", "Durand F", "Mookerjee RP", "Trebicka J", "Vargas V", "Piano S", "Watson H", "Abraldes JG", "Kamath PS", "Davis MM", "Ginès P", "investigators of the LIVERHOPE Consortium"], "date": "2022-05-01T00:00:00Z", "doi": "10.1002/hep4.1881", "meta_date_publication": "2022 May", "meta_volume": "6", "meta_issue": "5", "meta_pages": "1100-1112", "score": 50259.12, "text_hl": "Treatment With @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Rifaximin @CHEMICAL_MESH:D000078262 @@@Rifaximin@@@ Restores the Plasma Metabolomic Profile in @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Decompensated Cirrhosis@@@", "citations": {"NLM": "Pose E, Solà E, Lozano JJ, Juanola A, Sidorova J, Zaccherini G, de Wit K, Uschner F, Tonon M, Kazankov K, Jiménez C, Campion D, Napoleone L, Ma AT, Carol M, Morales-Ruiz M, Alessandria C, Beuers U, Caraceni P, Francoz C, Durand F, Mookerjee RP, Trebicka J, Vargas V, Piano S, Watson H, Abraldes JG, Kamath PS, Davis MM, Ginès P, investigators of the LIVERHOPE Consortium. Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis Hepatol Commun. 2022 May;6(5):1100-1112. PMID: 34964311", "BibTeX": "@article{34964311, title={Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis}, author={Pose E and Solà E and Lozano JJ and Juanola A and Sidorova J and Zaccherini G and de Wit K and Uschner F and Tonon M and Kazankov K and Jiménez C and Campion D and Napoleone L and Ma AT and Carol M and Morales-Ruiz M and Alessandria C and Beuers U and Caraceni P and Francoz C and Durand F and Mookerjee RP and Trebicka J and Vargas V and Piano S and Watson H and Abraldes JG and Kamath PS and Davis MM and Ginès P and investigators of the LIVERHOPE Consortium}, journal={Hepatol Commun}, volume={6}, number={5}, pages={1100-1112}}"}}, {"_id": "33033975", "pmid": 33033975, "title": "Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.", "journal": "Dig Dis Sci", "authors": ["Muñoz AE", "Pollarsky F", "Marino M", "Cartier M", "Míguez C", "Vázquez H", "Álvarez D", "Salgado P", "Romero G"], "date": "2021-09-01T00:00:00Z", "doi": "10.1007/s10620-020-06630-7", "meta_date_publication": "2021 Sep", "meta_volume": "66", "meta_issue": "9", "meta_pages": "3199-3208", "score": 50256.992, "text_hl": "AIM: We evaluate the safety of chronic @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@decompensated cirrhosis@@@. ", "citations": {"NLM": "Muñoz AE, Pollarsky F, Marino M, Cartier M, Míguez C, Vázquez H, Álvarez D, Salgado P, Romero G. Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury. Dig Dis Sci. 2021 Sep;66(9):3199-3208. PMID: 33033975", "BibTeX": "@article{33033975, title={Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.}, author={Muñoz AE and Pollarsky F and Marino M and Cartier M and Míguez C and Vázquez H and Álvarez D and Salgado P and Romero G}, journal={Dig Dis Sci}, volume={66}, number={9}, pages={3199-3208}}"}}]}